Negative methacholine challenge tests in subjects who report physician-diagnosed asthma

作者：McGrath K W; Fahy J V^*

来源：Clinical and Experimental Allergy, 2011, 41(1): 46-51.

DOI：10.1111/j.1365-2222.2010.03627.x

• asthma
• brochoprovocation testing
• diagnosis and assessment

P>Background
The frequency of adults reporting a history of asthma is rising. However, it is unclear whether this increased prevalence accurately demonstrates a rising trend or if it reflects an overall increase in asthma awareness.
Objective
To determine the frequency of negative methacholine bronchoprovocation tests in adults who report physician-diagnosed asthma and to explore the clinical characteristics of subjects with negative tests.
Methods
Data from methacholine challenge, spirometry, and physician assessment were analysed from 304 adults who reported physician-diagnosed asthma and responded to community-based advertising for asthma research studies. The clinical characteristics of methacholine-positive and -negative subjects were compared and a predictive model was tested to identify those characteristics associated with a negative test.
Results
Of the 304 subjects tested, 83 (27%) had a negative methacholine test. A negative test was positively associated with an adult-onset of symptoms (P < 0.001), normal forced expiratory volume in 1 s (P < 0.001), and having no history of exacerbation requiring oral steroids (P=0.03). Over half (60%) of those with a negative test reported weekly asthma-like symptoms (cough, dyspnoea, chest tightness, or wheeze), while 39% reported emergency department visits for asthma-like symptoms.
Conclusions and clinical relevance
A sizeable percentage of subjects who report physician-diagnosed asthma have a negative methacholine challenge test. These subjects are characterized by diagnosis of asthma as an adult and by normal or near normal spirometry. Caution should be exercised in the assessment and diagnosis of adults presenting with asthma-like symptoms, because they may not have asthma. Further diagnostic studies, including bronchoprovocation testing, are warranted in this patient group, especially if their spirometry is normal.
Cite this as: K. W. McGrath and J. V. Fahy, Clinical & Experimental Allergy, 2011 (41) 46-51.

• 出版日期2011-1